Brain Bleed Survivors Walk a Razor-Thin Line Taking DOACs

Watchdoq February 9, 2025
(MedPage Today) -- LOS ANGELES -- In the PRESTIGE-AF trial, survivors of intracerebral hemorrhage (ICH) had good protection against future ischemic events using direct oral anticoagulants (DOACs) -- though, as feared, bleeding side effects...

Read Full Article